Dermcidin: a novel human antibiotic peptide secreted by sweat glands.

PubWeight™: 2.29‹?› | Rank: Top 2%

🔗 View Article (PMID 11694882)

Published in Nat Immunol on December 01, 2001


B Schittek1, R Hipfel, B Sauer, J Bauer, H Kalbacher, S Stevanovic, M Schirle, K Schroeder, N Blin, F Meier, G Rassner, C Garbe

Author Affiliations

1: Department of Dermatology, Eberhard-Karls-University Tübingen, Germany.

Articles citing this

Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol (2012) 3.21

Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother (2004) 2.34

Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A (2007) 2.34

Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol (2007) 2.02

High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther (2007) 1.88

Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol (2008) 1.85

The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58

Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol (2011) 1.45

Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol (2007) 1.43

A neural survival factor is a candidate oncogene in breast cancer. Proc Natl Acad Sci U S A (2003) 1.41

Antimicrobial peptides: old molecules with new ideas. J Invest Dermatol (2011) 1.34

The role of antimicrobial peptides at the ocular surface. Ophthalmic Res (2008) 1.32

The role of microorganisms in atopic dermatitis. Clin Exp Immunol (2006) 1.31

Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. J Virol (2010) 1.27

Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 1.23

Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother (2006) 1.18

Antimicrobial peptides in human skin disease. Eur J Dermatol (2007) 1.17

Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids. Antimicrob Agents Chemother (2009) 1.16

Host defense peptides in wound healing. Mol Med (2008) 1.10

Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy. Br J Cancer (2006) 1.09

Peptidoglycan recognition protein 2 (N-acetylmuramoyl-L-Ala amidase) is induced in keratinocytes by bacteria through the p38 kinase pathway. Infect Immun (2005) 1.08

Temporal profiling of the secretome during adipogenesis in humans. J Proteome Res (2010) 1.07

Antimicrobial peptides, skin infections, and atopic dermatitis. Semin Cutan Med Surg (2008) 1.06

Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol (2010) 1.03

Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides. Int J Mol Sci (2014) 1.03

Bacterial sensing of antimicrobial peptides. Contrib Microbiol (2009) 1.03

Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues. Br J Cancer (2006) 1.01

Antimicrobial peptides: versatile biological properties. Int J Pept (2013) 1.01

Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf (2004) 1.00

Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men. J Infect Dis (2013) 0.99

Structure and mode of action of microplusin, a copper II-chelating antimicrobial peptide from the cattle tick Rhipicephalus (Boophilus) microplus. J Biol Chem (2009) 0.98

The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity. J Biol Chem (2008) 0.95

Structure-activity analysis of the dermcidin-derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat. J Biol Chem (2012) 0.94

Susceptibility to infectious diseases based on antimicrobial peptide production. Infect Immun (2009) 0.94

The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol (2012) 0.93

On the physiology and pathophysiology of antimicrobial peptides. Mol Med (2008) 0.93

Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections. Emerg Health Threats J (2009) 0.93

Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.92

Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J Immunol (2009) 0.92

Proteomics and deep sequencing comparison of seasonally active venom glands in the platypus reveals novel venom peptides and distinct expression profiles. Mol Cell Proteomics (2012) 0.91

Identification of RNase 8 as a novel human antimicrobial protein. Antimicrob Agents Chemother (2006) 0.91

Crystal structure and functional mechanism of a human antimicrobial membrane channel. Proc Natl Acad Sci U S A (2013) 0.91

Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases. Pharmaceuticals (Basel) (2015) 0.91

Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS One (2009) 0.90

HSP70 natively and specifically associates with an N-terminal dermcidin-derived peptide that contains an HLA-A*03 antigenic epitope. J Biol Chem (2011) 0.90

New Molecular Techniques to Study the Skin Microbiota of Diabetic Foot Ulcers. Adv Wound Care (New Rochelle) (2015) 0.90

Protecting the boundary: the sentinel role of host defense peptides in the skin. Cell Mol Life Sci (2011) 0.89

Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes. Br J Cancer (2003) 0.88

Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines. Br J Cancer (2008) 0.87

IL-17A and IFN-γ synergistically induce RNase 7 expression via STAT3 in primary keratinocytes. PLoS One (2013) 0.87

Antimicrobial activities of chemokines: not just a side-effect? Front Immunol (2012) 0.86

Chemerin is an antimicrobial agent in human epidermis. PLoS One (2013) 0.86

Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease. J Invest Dermatol (2011) 0.85

Mechanisms of resistance to antimicrobial peptides in staphylococci. Biochim Biophys Acta (2015) 0.85

Alternative approaches to antifungal therapies. Exp Dermatol (2012) 0.85

A cleavage-potentiated fragment of tear lacritin is bactericidal. J Biol Chem (2014) 0.84

Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9. J Neuroinflammation (2006) 0.83

Bacterial strategies of resistance to antimicrobial peptides. Philos Trans R Soc Lond B Biol Sci (2016) 0.82

Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria. Antibiotics (Basel) (2014) 0.82

Binding of Y-P30 to syndecan 2/3 regulates the nuclear localization of CASK. PLoS One (2014) 0.81

Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins. PLoS One (2013) 0.81

Skin Physiology of the Neonate and Infant: Clinical Implications. Adv Wound Care (New Rochelle) (2015) 0.80

Sphingolipids and antimicrobial peptides: function and roles in atopic dermatitis. Biomol Ther (Seoul) (2013) 0.80

Molecular characterization of skin microbiota between cancer cachexia patients and healthy volunteers. Microb Ecol (2014) 0.80

Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent. FEMS Microbiol Lett (2014) 0.80

Quantitative proteomics of the human skin secretome reveal a reduction in immune defense mediators in ectodermal dysplasia patients. J Invest Dermatol (2014) 0.80

Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF). Br J Cancer (2011) 0.79

Differential protein expression in seminal plasma from fertile and infertile males. J Hum Reprod Sci (2014) 0.78

Development of highly sensitive and specific mRNA multiplex system (XCYR1) for forensic human body fluids and tissues identification. PLoS One (2014) 0.78

The Importance of Acidification in Atopic Eczema: An Underexplored Avenue for Treatment. J Clin Med (2015) 0.78

Host Defense Proteins in Breast Milk and Neonatal Yeast Colonization. J Hum Lact (2015) 0.77

Functions of alternative replication protein A in initiation and elongation. Biochemistry (2010) 0.77

Characterisation of the immune compounds in koala milk using a combined transcriptomic and proteomic approach. Sci Rep (2016) 0.76

The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour. BMC Gastroenterol (2005) 0.76

Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy. Br J Cancer (2007) 0.76

Antimicrobial Protection of Marsupial Pouch Young. Front Microbiol (2017) 0.75

Skin-Derived C-Terminal Filaggrin-2 Fragments Are Pseudomonas aeruginosa-Directed Antimicrobials Targeting Bacterial Replication. PLoS Pathog (2015) 0.75

Gross cystic disease fluid protein 15 in stratum corneum is a potential marker of decreased eccrine sweating for atopic dermatitis. PLoS One (2015) 0.75

Analysis of Y-P30/Dermcidin expression and properties of the Y-P30 peptide. BMC Res Notes (2014) 0.75

Expression of dermcidin in human sinonasal secretions. Int Forum Allergy Rhinol (2016) 0.75

Proteomics Study on Nonallergic Hypersensitivity Induced by Compound 4880 and Ovalbumin. PLoS One (2016) 0.75

In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2014) 0.75

The in Vitro Immune-Modulating Properties of a Sweat Gland-Derived Antimicrobial Peptide Dermcidin. Shock (2016) 0.75

Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling. BMC Cancer (2015) 0.75

pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents. Pharmaceuticals (Basel) (2016) 0.75

Characterization of released polypeptides during an interferon-γ-dependent antibacterial response in airway epithelial cells. J Interferon Cytokine Res (2012) 0.75

Multiple Functions of the New Cytokine-Based Antimicrobial Peptide Thymic Stromal Lymphopoietin (TSLP). Pharmaceuticals (Basel) (2016) 0.75

Antimicrobial Peptides Share a Common Interaction Driven by Membrane Line Tension Reduction. Biophys J (2016) 0.75

Conservative procedures in skin reconstitution. GMS Curr Top Otorhinolaryngol Head Neck Surg (2005) 0.75

Structural and Functional Consequences Induced by Post-Translational Modifications in α-Defensins. Int J Pept (2011) 0.75

Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis. PLoS One (2014) 0.75

A novel organotypic 3D sweat gland model with physiological functionality. PLoS One (2017) 0.75

Articles by these authors

A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res (1976) 24.00

Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A (1996) 12.92

Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56

Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J (1999) 10.82

Isolation of large molecular weight DNA from agarose gels for further digestion by restriction enzymes. FEBS Lett (1975) 9.87

Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 9.19

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44

Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05

Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98

Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.84

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06

A tunable topological insulator in the spin helical Dirac transport regime. Nature (2009) 4.98

Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A (1999) 4.84

Observation of unconventional quantum spin textures in topological insulators. Science (2009) 3.58

Bacteriophage P1 cre gene and its regulatory region. Evidence for multiple promoters and for regulation by DNA methylation. J Mol Biol (1986) 2.80

Genomic targeting with purified Cre recombinase. Nucleic Acids Res (1993) 2.74

Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ (2001) 2.72

Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci U S A (1992) 2.72

Topological phase transition and texture inversion in a tunable topological insulator. Science (2011) 2.68

Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis (1999) 2.66

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27

Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem (1998) 2.24

Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol (2001) 2.24

Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23

Observation of time-reversal-protected single-dirac-cone topological-insulator states in Bi2Te3 and Sb2Te3. Phys Rev Lett (2009) 2.22

A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy. Proc Natl Acad Sci U S A (1992) 2.20

Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci (1993) 2.08

Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N Engl J Med (1997) 2.05

Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett (1987) 2.04

Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol (2002) 2.03

[Activity pattern of enzymes of the energy producing metabolism in the normal human epidermis and in psoriasis vulgaris. II]. Arch Klin Exp Dermatol (1966) 1.95

Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet (1997) 1.95

Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (2000) 1.92

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia (2001) 1.91

Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev (2006) 1.89

Transfusion medicine monitoring practices. A study of the College of American Pathologists/Centers for Disease Control and Prevention Outcomes Working Group. Arch Pathol Lab Med (1995) 1.87

Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev (2005) 1.87

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85

Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med (1994) 1.85

Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (2008) 1.84

Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol (1998) 1.81

Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol (1990) 1.80

IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80

Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol (1999) 1.79

A bacterial mutation blocking P2 phage late gene expression. Proc Natl Acad Sci U S A (1975) 1.79

The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci (1994) 1.76

Effects of cytokines on the liver. Hepatology (1991) 1.76

Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proc Natl Acad Sci U S A (1998) 1.72

Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol (1997) 1.72

Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol (2002) 1.71

Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma. J Clin Epidemiol (1997) 1.69

Predictors of MCAT scores for black Americans. J Natl Med Assoc (1987) 1.68

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br J Cancer (2007) 1.67

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66

Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol (1996) 1.65

On the association between valproate and polycystic ovary syndrome. Epilepsia (2001) 1.65

Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J (1991) 1.65

Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am J Respir Cell Mol Biol (2001) 1.65

Cleavage of zearalenone-glycoside, a "masked" mycotoxin, during digestion in swine. Zentralbl Veterinarmed B (1990) 1.64

Two new proteases in the MHC class I processing pathway. Nat Immunol (2000) 1.63

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut (2003) 1.62

Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol (1998) 1.62

Site-directed recombination in the genome of transgenic tobacco. Mol Gen Genet (1990) 1.60

Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer (1997) 1.59

Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J Biol Chem (1998) 1.57

Erythrocyte K-Cl cotransport: properties and regulation. Am J Physiol (1992) 1.56

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol (2001) 1.56

Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol (1998) 1.54

Arrangement of coding and intervening sequences of chicken lysozyme gene. Proc Natl Acad Sci U S A (1979) 1.53

Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol (1998) 1.52

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood (1999) 1.52

The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol (1997) 1.52

Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol (1993) 1.52

How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials. Fam Pract (2007) 1.51

Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma. Arch Dermatol (1995) 1.50

Urine culture contamination: a College of American Pathologists Q-Probes study of contaminated urine cultures in 906 institutions. Arch Pathol Lab Med (1998) 1.50

Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49

Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol (2001) 1.49

Limit of T cell tolerance to self proteins by peptide presentation. Science (1990) 1.49

Genetic analysis of bacteriophage P4 using P4-plasmid ColE1 hybrids. Mol Gen Genet (1980) 1.48

Multidimensional assessment of personality in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry (2004) 1.48

E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest (1999) 1.47

Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain (2000) 1.47

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J Immunol (2001) 1.46

Patterns of local horizontal spread of melanomas: consequences for surgery and histopathologic investigation. Am J Surg Pathol (1999) 1.45